Significant Ownership of NORTH RUN CAPITAL, LP

Signature - Title
/s/ Michael Fisher - Michael Fisher / Attorney-in-Fact for Thomas B. Ellis and Todd B. Hammer, Members of General Partner
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by NORTH RUN CAPITAL, LP.

Notify me when NORTH RUN CAPITAL, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of NORTH RUN CAPITAL, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LNSR LENSAR, Inc. Common Stock, $0.01 par value 56% $182,599,804 13,535,938 ELLIS THOMAS B 23 Mar 2025
SCND Scientific Industries, Inc. Common Stock, par value $0.05 per share 10% $880,328 1,189,632 0% North Run Capital, LP 30 Sep 2025
TELA TELA Bio, Inc. Common Stock, $0.001 par value per share 9.3% $3,608,839 3,682,489 North Run Capital, LP 31 Mar 2025

Schedules 13D/G Reported by NORTH RUN CAPITAL, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.